CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Survivorship

OBGYN.net.
CLINICAL UPDATE 

After Breast Cancer, Omega-3s Fight Fatigue

By Heidi Anne Duerr, MPH | April 16, 2012

Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.

Dr. Catherine M. Alfano, of the Office of Cancer Survivorship in the National Cancer Institute in Bethesda, Maryland, and colleagues conducted a study that looked at the relationship between omega-3 intake and fatigue in breast cancer survivors (N=633; mean age=56). Participants completed dietary questionnaires, provided blood samples (which were assayed for C-reactive protein and serum amyloid A at 30 months after diagnosis), and completed self-report fatigue scales 39 months following diagnosis. Alfano and colleagues examined the relationships between inflammation and fatigue, inflammation and intake of omega-3 and omega-6 polyunsaturated fatty acids, and fatigue and intake of polyunsaturated fatty acids. The researchers looked at dietary sources of omega-3 polyunsaturated fatty acids as well as fish oil supplements as part of their analysis.

The researchers found that behavioral and sensory fatigue scale scores were higher by increasing C-reactive protein tertiles. Specifically, Alfano noted that participants with high C-reactive protein levels had 1.8 times greater odds of fatigue after full adjustment for confounders. They also found that greater intakes of omega-6 relative to omega-3 was associated with greater high C-reactive protein and greater odds of experiencing fatigue, with an odds ratio of 2.6 for the highest versus the lowest intake.

“Results link higher intake of ω-3 PUFAs [omega-3 polyunsaturated fatty acids], decreased inflammation, and decreased physical aspects of fatigue,” Alfano and colleagues concluded. “Future studies should test whether ω-3 supplementation may reduce fatigue among significantly fatigued breast cancer survivors.”

While the researchers noted further studies were necessary before recommending fish oil supplements to breast cancer survivors, they added that consuming fish, especially fatty fish high in omega-3 polyunsaturated fatty acids, may a good idea.

Related Content

New Blood Test Improves Detection of Recurrent Breast Cancer
Group CBT Relieves Menopause Symptoms After Breast Cancer
 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





References:
Alfano CM, Imayama I, Neuhouser ML, et al. Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. J Clin Oncol. 2012; Mar 12 [Epub].
Norton A. Omega-3 fat tied to less cancer-related fatigue. Medscape News. March 29, 2012.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Survivorship
Evidence on Survivorship
Guidelines on Survivorship
Patient Education on Survivorship
Clinical Trials on Survivorship
Practical Articles on Survivorship
Research and Reviews on Survivorship
All "Survivorship" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy